Use of tolvaptan vs. furosemide in older patients with heart failure Meta-analysis of randomized controlled trials

摘要

It is not known whether older patients with acute heart failure (HF) receiving tolvaptan have decreased mortality rates and a better long-term prognosis than patients who receive furosemide. We conducted a systematic review of randomized controlled trials (RCTs) to address this issue.